ESC Premium Access

Efficacy and safety of various doses of the new dual endothelin receptor antagonist aprocitentan in the treatment of hypertension

Presentation

About the speaker

Ms Parisa Danaietash

Idorsia Pharmaceuticals Ltd, Allschwil (Switzerland)
0 follower

3 more presentations in this session

State of the Art - Drug treatment in hypertension: unmet needs

Speaker: Professor B. Williams (London, GB)

Thumbnail

Can anti-hypertensive thiazide diuretics also reduce fragility fracture risk?

Speaker: Doctor J. Sousa (Coimbra, PT)

Thumbnail

New targets for blood pressure lowering drugs

Speaker: Professor G. Parati (Milan, IT)

Thumbnail

Access the full session

Drug treatment in hypertension - New insights

Speakers: Ms P. Danaietash, Professor B. Williams, Doctor J. Sousa, Professor G. Parati
Thumbnail

About the event

Image

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

This platform is supported by

logo Novo Nordisk